Weighted Average Number of Shares Outstanding, Basic of Viking Therapeutics, Inc. from 31 Mar 2017 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Viking Therapeutics, Inc. quarterly and annual Weighted Average Number of Shares Outstanding, Basic in shares history and change rate from 31 Mar 2017 to 31 Dec 2025.
  • Viking Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending 31 Dec 2025 was 112,667,303, a 3.3% increase year-over-year.
  • Viking Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2025 was 112,667,303, a 3.3% increase from 2024.
  • Viking Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 109,037,122, a 16% increase from 2023.
  • Viking Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 94,346,991, a 23% increase from 2022.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Change (%)

Viking Therapeutics, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 112,667,303 +3,630,181 +3.3% 01 Oct 2025 31 Dec 2025 10-K 11 Feb 2026 2025 FY
Q3 2025 112,319,770 +1,409,066 +1.3% 01 Jul 2025 30 Sep 2025 10-Q 23 Oct 2025 2025 Q3
Q2 2025 112,134,425 +1,744,254 +1.6% 01 Apr 2025 30 Jun 2025 10-Q 23 Jul 2025 2025 Q2
Q1 2025 112,069,078 +8,611,773 +8.3% 01 Jan 2025 31 Mar 2025 10-Q 24 Apr 2025 2025 Q1
Q4 2024 109,037,122 +14,690,131 +16% 01 Oct 2024 31 Dec 2024 10-K 11 Feb 2026 2025 FY
Q3 2024 110,910,704 +11,064,971 +11% 01 Jul 2024 30 Sep 2024 10-Q 23 Oct 2025 2025 Q3
Q2 2024 110,390,171 +11,380,461 +11% 01 Apr 2024 30 Jun 2024 10-Q 23 Jul 2025 2025 Q2
Q1 2024 103,457,305 +25,105,479 +32% 01 Jan 2024 31 Mar 2024 10-Q 24 Apr 2025 2025 Q1
Q4 2023 94,346,991 +17,513,361 +23% 01 Oct 2023 31 Dec 2023 10-K 11 Feb 2026 2025 FY
Q3 2023 99,845,733 +23,340,350 +31% 01 Jul 2023 30 Sep 2023 10-Q 23 Oct 2024 2024 Q3
Q2 2023 99,009,710 +22,167,725 +29% 01 Apr 2023 30 Jun 2023 10-Q 24 Jul 2024 2024 Q2
Q1 2023 78,351,826 +938,685 +1.2% 01 Jan 2023 31 Mar 2023 10-Q 25 Apr 2024 2024 Q1
Q4 2022 76,833,630 01 Oct 2022 31 Dec 2022 10-K 26 Feb 2025 2024 FY
Q3 2022 76,505,383 -1,503,446 -1.9% 01 Jul 2022 30 Sep 2022 10-Q 25 Oct 2023 2023 Q3
Q2 2022 76,841,985 -1,054,609 -1.4% 01 Apr 2022 30 Jun 2022 10-Q 26 Jul 2023 2023 Q2
Q1 2022 77,413,141 01 Jan 2022 31 Mar 2022 10-Q 26 Apr 2023 2023 Q1
Q3 2021 78,008,829 01 Jul 2021 30 Sep 2021 10-Q 26 Oct 2022 2022 Q3
Q2 2021 77,896,594 01 Apr 2021 30 Jun 2021 10-Q 27 Jul 2022 2022 Q2
Q1 2019 71,755,137 +27,106,338 +61% 01 Jan 2019 31 Mar 2019 10-Q 02 May 2019 2019 Q1
Q3 2018 61,231,680 +33,761,896 +123% 01 Jul 2018 30 Sep 2018 10-Q 07 Nov 2018 2018 Q3
Q2 2018 52,767,111 +28,648,224 +119% 01 Apr 2018 30 Jun 2018 10-Q 09 Aug 2018 2018 Q2
Q1 2018 44,648,799 +22,295,878 +100% 01 Jan 2018 31 Mar 2018 10-Q 02 May 2019 2019 Q1
Q3 2017 27,469,784 01 Jul 2017 30 Sep 2017 10-Q 07 Nov 2018 2018 Q3
Q2 2017 24,118,887 01 Apr 2017 30 Jun 2017 10-Q 09 Aug 2018 2018 Q2
Q1 2017 22,352,921 01 Jan 2017 31 Mar 2017 10-Q 09 May 2018 2018 Q1

Viking Therapeutics, Inc. Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 112,667,303 +3,630,181 +3.3% 01 Jan 2025 31 Dec 2025 10-K 11 Feb 2026 2025 FY
2024 109,037,122 +14,690,131 +16% 01 Jan 2024 31 Dec 2024 10-K 11 Feb 2026 2025 FY
2023 94,346,991 +17,513,361 +23% 01 Jan 2023 31 Dec 2023 10-K 11 Feb 2026 2025 FY
2022 76,833,630 -364,050 -0.47% 01 Jan 2022 31 Dec 2022 10-K 26 Feb 2025 2024 FY
2021 77,197,680 01 Jan 2021 31 Dec 2021 10-K 07 Feb 2024 2023 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.